Skip to main content

Table 1 Incidence rates of BTC in the United States by anatomic site and sex, ASR: 2001–2015 [26]

From: Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015

 

BTC,

ASR (95% CI; N = 174,819)

GBC,

ASR (95% CI; N = 54,214)

ICC,

ASR (95% CI; N = 40,967)

ECC,

ASR (95% CI; N = 43,188)

AVC,

ASR (95% CI; N = 26,356)

Overlapping & NOS,

ASR (95% CI; N = 10,094)

Combined

5.04 (5.02 to 5.06)

1.57 (1.56 to 1.58)

1.17 (1.16 to 1.19)

1.25 (1.24 to 1.26)

0.76 (0.75 to 0.77)

0.29 (0.29 to 0.30)

Male

5.31 (5.27 to 5.34)

1.14 (1.12 to 1.16)

1.33 (1.31 to 1.35)

1.55 (1.53 to 1.57)

0.97 (0.95 to 0.98)

0.33 (0.32 to 0.34)

Female

4.85 (4.82 to 4.89)

1.92 (1.90 to 1.94)

1.05 (1.04 to 1.07)

1.02 (1.01 to 1.04)

0.61 (0.60 to 0.62)

0.26 (0.25 to 0.27)

  1. Incidence rates are age-standardized and reported as cases per 100,000 person-years
  2. ASR Age-standardized rate, AVC Ampulla of Vater cancer, BTC Biliary tract cancer, CI Confidence interval, ECC Extrahepatic cholangiocarcinoma, GBC Gallbladder cancer, ICC intrahepatic cholangiocarcinoma, NOS Not otherwise specified